Hepatitis C infection in African Americans: Its natural history and histological progression

American Journal of Gastroenterology

Volumn 97, Issue 3, 2002, Pages 700-706

  Wiley, Thelma E ^a,b   Brown, Jennifer ^a   Chan, Juliana ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b M/C 787 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; DISEASE COURSE; ETHNIC GROUP; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HISTORY; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 0036129997     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)04117-X     Document Type: Article

References (41)

1. National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C
2. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C
3. Impact of alcohol on the histological and clinical progression of hepatitis C infection
4. Natural history of liver fibrosis progression in patients with chronic hepatitis C
5. Chronic hepatitis C: Effect of alcohol on hepatitic activity and viral titre
6. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
7. Randomized trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
8. Factors associated with severity and disease progression in chronic hepatitis C
9. Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial
10. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy
11. The natural course of chronic hepatitis C: A comparison between patients with genotypes 1 and 2 hepatitis C viruses
12. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
13. Racial differences in responses to therapy with interferon in chronic hepatitis C
14. The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C
15. African-American response rate to therapy for hepatitis C
16. Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alpha
17. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
18. Diagnostic tests for hepatitis C
19. Typing hepatitis C virus by polymerase chain reaction with type specific primers application to clinical surveys, and tracing infection sources
20. 45 Year follow-up on hepatitis C virus infection in healthy young adults
21. Prognosis of chronic hepatitis C: Results of a large, prospective cohort study
22. Long-term clinical, and histopathological follow-up of chronic posttransfusion hepatitis
23. The natural history of community-acquired hepatitis C in the United States
24. Hepatitis B, and C in HIV-infected patients. Prevalence and prognostic value
25. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis
26. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virusassociated chronic liver disease: Clinical and virological significance
27. The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks
28. Hepatitis C virus genotypes are not responsible for development of serious liver disease
29. Hepatitis C viral dynamics in vivo, and the antiviral efficacy of interferonalpha-therapy
30. Pretreatment differences between HCV-infected African American and non-African American patients
31. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocye activity, and response to interferon alfa therapy in chronic hepatitis C
32. Differential cytotoxic T lymphocyte responsiveness to the hepatitis B, and C viruses in chronically infected patients
33. Cytotoxic T lymphocyte response, and viral load in hepatitis C virus infection
34. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C
35. Hepatitis C virusspecific cytolytic T lymphocyte, and T helper cell responses in seronegative persons
36. Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival
37. Race-related differences in HLA association with ankylosing spondylitis and Reiter's disease in American blacks and whites
38. Association between HLA class II genotype, and spontaneous clearance of hepatitis C viraemia
39. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection
40. Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels
41. HLA-DR5 antigen: A genetic factor influencing the outcome of hepatitis C virus infection